Zuari Agro Chemicals Limited (NSE:ZUARI)

Intra-Cellular Therapies Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	-	2,124	3,379	3,892	5,655	4,273
Short-Term Investments	-	-	110.01	0.53	200.01	340.01
Cash & Short-Term Investments	2,124	2,124	3,489	3,893	5,855	4,613
Cash Growth	-45.35%	-39.13%	-10.36%	-33.52%	26.92%	74.06%
Accounts Receivable	-	861.6	5,980	7,802	6,335	4,539
Other Receivables	-	-	1,181	1,232	401.28	388.23
Receivables	-	861.7	7,161	9,034	6,736	4,928
Inventory	-	1,723	3,161	3,987	5,039	2,216
Prepaid Expenses	-	-	168.9	151.69	183.78	138.8
Restricted Cash	-	-	14.29	-	-	-
Other Current Assets	-	22,234	833.7	878.31	15,047	15,188
Total Current Assets	-	26,943	14,828	17,943	32,861	27,083
Property, Plant & Equipment	-	7,576	18,620	18,431	16,290	13,915
Long-Term Investments	-	14,250	12,699	12,424	11,266	9,517
Goodwill	-	-	156.51	156.51	156.51	156.51
Other Intangible Assets	-	1,116	995.88	970.33	955.84	988.06
Long-Term Deferred Tax Assets	-	62.3	85.08	18.77	697.78	674.12
Other Long-Term Assets	-	317.9	813.91	573.24	394.82	1,384
Total Assets	-	50,264	48,199	50,517	62,623	53,719
Accounts Payable	-	1,590	3,386	4,834	5,872	4,083
Accrued Expenses	-	7.4	394.55	424.16	570.98	631.28
Short-Term Debt	-	-	11,784	10,308	16,521	8,537
Current Portion of Long-Term Debt	-	4,991	612.54	4,263	4,116	3,975
Current Portion of Leases	-	103.8	109.75	3.61	59.59	53.33
Current Income Taxes Payable	-	-	176.95	159.24	83.88	19.53
Current Unearned Revenue	-	-	985.44	1,221	959.09	696.57
Other Current Liabilities	-	16,262	1,265	857.51	19,574	22,920
Total Current Liabilities	-	22,954	18,714	22,071	47,756	40,916
Long-Term Debt	-	1,347	4,341	5,569	5,067	5,212
Long-Term Leases	-	731.3	982.76	932.48	668.28	732.24
Long-Term Unearned Revenue	-	-	1.71	1.71	3.41	5.12
Long-Term Deferred Tax Liabilities	-	-	1,040	614.99	510.67	278.77
Other Long-Term Liabilities	-	57.5	61.33	37.89	33.4	39.3
Total Liabilities	-	25,089	25,301	29,374	54,178	47,331
Common Stock	-	420.6	420.58	420.58	420.58	420.58
Retained Earnings	-	-	-3,345	-4,330	-9,210	-10,511
Comprehensive Income & Other	-	18,138	19,864	19,721	12,460	12,053
Total Common Equity	18,559	18,559	16,939	15,812	3,670	1,962
Minority Interest	-	6,616	5,958	5,332	4,774	4,426
Shareholders' Equity	25,175	25,175	22,898	21,143	8,444	6,388
Total Liabilities & Equity	-	50,264	48,199	50,517	62,623	53,719
Total Debt	7,173	7,173	17,830	21,076	26,431	18,510
Net Cash (Debt)	-5,049	-5,049	-14,341	-17,184	-20,576	-13,897
Net Cash Per Share	-57.62	-120.03	-340.98	-408.58	-489.23	-330.42
Filing Date Shares Outstanding	224.47	42.03	42.06	42.06	42.06	42.06
Total Common Shares Outstanding	224.47	42.03	42.06	42.06	42.06	42.06
Working Capital	-	3,989	-3,886	-4,128	-14,895	-13,833
Book Value Per Share	441.52	441.52	402.76	375.95	87.26	46.65
Tangible Book Value	17,443	17,443	15,787	14,685	2,558	817.36
Tangible Book Value Per Share	414.97	414.97	375.36	349.16	60.81	19.43
Land	-	-	6,747	-	6,745	6,412
Buildings	-	-	1,081	-	1,170	1,158
Machinery	-	-	13,688	-	7,405	7,188
Construction In Progress	-	-	135.64	-	3,201	782.62

Updated Feb 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.